The Application of Digital Intelligent Diagnostic and Therapeutic Technology in Biliary Dilation Diagnosis

Launched by ZHUJIANG HOSPITAL · May 15, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new technology that uses augmented reality and three-dimensional imaging to help doctors perform safer and more precise surgeries for conditions like congenital biliary dilatation and choledochal cysts. The goal is to reduce the risk of injuries to important blood vessels and bile ducts during surgery, which can lead to serious complications after the operation.

If you or a loved one has been diagnosed with congenital biliary dilatation and meets certain health criteria, you might be eligible to participate in this study. Participants should have stable liver function (class A or B) and complete medical records. However, individuals with severe heart or lung problems, those with cancer, or incomplete medical information will not qualify. If you join the trial, you can expect to be part of a cutting-edge approach to surgery that aims to improve outcomes and reduce complications. The trial is currently recruiting participants of all ages, from 58 to 273 years old.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of congenital biliary dilatation confirmed; The standard of Child-Pugh classification of preoperative liver function was; class A or B; Clinical data were complete;
• Exclusion Criteria:
• • Patients with cardiopulmonary dysfunction who cannot tolerate surgery or anesthesia; Patients with malignant transformation; Lack of clinical data.